In order to find suitable models to test our vaccine, we screened several tumor cell lines, and in line with FOXL2 expression restriction in female organs, we found only modest levels of Foxl2 cDNA in 2 ovarian cancer cell lines (BR5 and ID8) and 1 breast cancer cell line (4T1). This evidence concerns the gene FOXL2 and breast carcinoma.